Status:
COMPLETED
Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants
Lead Sponsor:
ByHeart
Collaborating Sponsors:
Paidion Research, Inc.
Conditions:
Healthy
Term Infants
Eligibility:
All Genders
16-19 years
Phase:
NA
Brief Summary
The purpose of this two-month follow-up study is to continue to follow growth, safety, and other health outcomes of infants fed a new infant formula for term infants or comparator formula. A reference...
Eligibility Criteria
Inclusion
- Subjects who enrolled and completed the previous phase of the clinical trial: NCT04218929 "Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants"
Exclusion
- Subjects who did not enroll in the previous phase of the clinical trial: NCT04218929 "Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants"
Key Trial Info
Start Date :
May 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 11 2021
Estimated Enrollment :
311 Patients enrolled
Trial Details
Trial ID
NCT04389606
Start Date
May 12 2020
End Date
June 11 2021
Last Update
July 21 2021
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
Alabama Clinical Therapeutics
Birmingham, Alabama, United States, 35126
2
Watching Over Mothers and Babies
Tucson, Arizona, United States, 85712
3
The Children's Clinic of Jonesboro, P.A.
Jonesboro, Arkansas, United States, 72401
4
Applied Research Center of Arkansas
Little Rock, Arkansas, United States, 72212